» Authors » Habibeh Khoshbouei

Habibeh Khoshbouei

Explore the profile of Habibeh Khoshbouei including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 85
Citations 2177
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Gopinath A, Apicella A, Smith A, Bertero A, Freedman E, Hornstein L, et al.
bioRxiv . 2024 Dec; PMID: 39713440
Midbrain dopamine neurons are well-known to shape central nervous system function, yet there is growing evidence for their influence on the peripheral immune systems. Here we demonstrate that midbrain dopamine...
2.
Gopinath A, Ramirez-Zamora A, Franks S, Riaz T, Smith A, Dizon G, et al.
J Parkinsons Dis . 2024 May; 14(4):883-888. PMID: 38788089
Background: Parkinson's disease (PD) is the second most common neurodegenerative disorder, with genetic factors accounting for about 15% of cases. There is a significant challenge in tracking disease progression and...
3.
Tian J, Mallinger J, Shi P, Ling D, Deleyrolle L, Lin M, et al.
Transl Oncol . 2024 Apr; 45:101956. PMID: 38640786
Tumor Treating Fields (TTFields) extend the survival of glioblastoma (GBM) patients by interfering with a broad range of tumor cellular processes. Among these, TTFields disrupt primary cilia stability on GBM...
4.
Miller E, Khoshbouei H
Adv Pharmacol . 2024 Mar; 99:217-250. PMID: 38467482
Methamphetamine (METH) regulation of the dopamine transporter (DAT) and central nervous system (CNS) dopamine transmission have been extensively studied. However, our understanding of how METH influences neuroimmune communication and innate...
5.
Camacho-Hernandez G, Gopinath A, Okorom A, Khoshbouei H, Newman A
JACS Au . 2024 Mar; 4(2):657-665. PMID: 38425927
The dopamine transporter (DAT) is one of the key regulators of dopamine (DA) signaling in the central nervous system (CNS) and in the periphery. Recent reports in a model of...
6.
Bu M, Follett J, Deng I, Tatarnikov I, Wall S, Guenther D, et al.
NPJ Parkinsons Dis . 2023 Dec; 9(1):167. PMID: 38110354
Dysregulation of dopamine neurotransmission profoundly affects motor, motivation and learning behaviors, and can be observed during the prodromal phase of Parkinson's disease (PD). However, the mechanism underlying these pathophysiological changes...
7.
Larochelle J, Tishko R, Yang C, Ge Y, Phan L, Gunraj R, et al.
J Neuroinflammation . 2023 Sep; 20(1):221. PMID: 37777791
Background: Receptor-interacting protein kinase 2 (RIPK2) is a serine/threonine kinase whose activity propagates inflammatory signaling through its association with pattern recognition receptors (PRRs) and subsequent TAK1, NF-κB, and MAPK pathway...
8.
Nutter C, Kidd B, Carter H, Hamel J, Mackie P, Kumbkarni N, et al.
Brain . 2023 May; 146(10):4217-4232. PMID: 37143315
Myotonic dystrophy type 1 is a dominantly inherited multisystemic disease caused by CTG tandem repeat expansions in the DMPK 3' untranslated region. These expanded repeats are transcribed and produce toxic...
9.
Gopinath A, Riaz T, Miller E, Phan L, Smith A, Syed O, et al.
Basic Clin Pharmacol Toxicol . 2023 Jan; 133(5):496-507. PMID: 36710070
Methamphetamine is a widely abused psychostimulant and one of the main targets of dopamine transporter (DAT). Methamphetamine reduces DAT-mediated dopamine uptake and stimulates dopamine efflux leading to increased synaptic dopamine...
10.
Gopinath A, Mackie P, Phan L, Mirabel R, Smith A, Miller E, et al.
Cells . 2023 Jan; 12(2). PMID: 36672204
The dopamine transporter (DAT) regulates the dimension and duration of dopamine transmission. DAT expression, its trafficking, protein-protein interactions, and its activity are conventionally studied in the CNS and within the...